Építés alatt – nem éles oldal
Belépés

Szarkóma trials, also abroad

604 open Szarkóma trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Egyesült Államok301
Kína106
Franciaország71
Olaszország52
Spanyolország39
All other countries

The same trial often runs in several countries

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J) has 2 sites in Thaiföld and runs in 14 countries. If a site near you is full, another one may still take people.

See KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J) in all 14 countries
Építés alatt, nem éles – Szarkóma: vizsgálatok itt: Thaiföld – Frontlight Research